Regeneron CEO Says Trump Receiving Experimental Antibody Treatment Creates ‘Very Tough Situation’

Regeneron CEO Says Trump Receiving Experimental Antibody Treatment Creates ‘Very Tough Situation’

Source: 
Forbes
snippet: 

Treating the president with Regeneron’s experimental antibody therapy creates a “very tough situation” for the company as the therapy has not received approval for widespread use, the company’s CEO said.